Both in Health Services
Mangoceuticals vs P3 Health Partners
Over the past year MGRX returned −78.9% and PIII returned −32.0%; their daily moves had a correlation of 0.04.
MGRX −78.9% PIII −32.0%Growth of $1, one year, split-adjusted
| Metric | MGRX | PIII |
|---|---|---|
| Price | $0.4445 | $6.54 |
| Market cap | $9.6M | $25.6M |
| Today | +15.51% | −5.76% |
| 1 month | +10.5% | −29.1% |
| 6 months | +3.9% | +120.9% |
| Year to date | −39.9% | +87.4% |
| 1 year | −79.4% | — |
| Revenue growth (YoY) | −37.9% | +8.6% |
| Gross margin | 87.9% | 22.3% |
| Net margin | −5447.9% | −0.6% |
| P/E (TTM) | — | — |
| Price / sales | 23.1× | 0.0× |
| Net cash | $174.6K | -$99.0M |
| Dividend yield | — | — |
| Volatility (60d) | 220.9% | 62.7% |
| Short % of float | 3.4% | 2.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).